Literature DB >> 7720572

Embryonic activation of the myoD gene is regulated by a highly conserved distal control element.

D J Goldhamer1, B P Brunk, A Faerman, A King, M Shani, C P Emerson.   

Abstract

MyoD belongs to a small family of basic helix-loop-helix transcription factors implicated in skeletal muscle lineage determination and differentiation. Previously, we identified a transcriptional enhancer that regulates the embryonic expression of the human myoD gene. This enhancer had been localized to a 4 kb fragment located 18 to 22 kb upstream of the myoD transcriptional start site. We now present a molecular characterization of this enhancer. Transgenic and transfection analyses localize the myoD enhancer to a core sequence of 258 bp. In transgenic mice, this enhancer directs expression of a lacZ reporter gene to skeletal muscle compartments in a spatiotemporal pattern indistinguishable from the normal myoD expression domain, and distinct from expression patterns reported for the other myogenic factors. In contrast to the myoD promoter, the myoD enhancer shows striking conservation between humans and mice both in its sequence and its distal position. Furthermore, a myoD enhancer/heterologous promoter construct exhibits muscle-specific expression in transgenic mice, demonstrating that the myoD promoter is dispensable for myoD activation. With the exception of E-boxes, the myoD enhancer has no apparent sequence similarity with regulatory regions of other characterized muscle-specific structural or regulatory genes. Mutation of these E-boxes, however, does not affect the pattern of lacZ transgene expression, suggesting that myoD activation in the embryo is E-box-independent. DNase I protection assays reveal multiple nuclear protein binding sites in the core enhancer, although none are strictly muscle-specific. Interestingly, extracts from myoblasts and 10T1/2 fibroblasts yield identical protection profiles, indicating a similar complement of enhancer-binding factors in muscle and this non-muscle cell type. However, a clear difference exists between myoblasts and 10T1/2 cells (and other non-muscle cell types) in the chromatin structure of the chromosomal myoD core enhancer, suggesting that the myoD enhancer is repressed by epigenetic mechanisms in 10T1/2 cells. These data indicate that myoD activation is regulated at multiple levels by mechanisms that are distinct from those controlling other characterized muscle-specific genes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7720572     DOI: 10.1242/dev.121.3.637

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  56 in total

1.  TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3.

Authors:  D Liu; B L Black; R Derynck
Journal:  Genes Dev       Date:  2001-11-15       Impact factor: 11.361

2.  Transgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue-dependent changes in radiation-induced activation during embryogenesis.

Authors:  E Gottlieb; R Haffner; A King; G Asher; P Gruss; P Lonai; M Oren
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

3.  MASTR directs MyoD-dependent satellite cell differentiation during skeletal muscle regeneration.

Authors:  Mayssa H Mokalled; Aaron N Johnson; Esther E Creemers; Eric N Olson
Journal:  Genes Dev       Date:  2012-01-15       Impact factor: 11.361

4.  Myogenic transcriptional activation of MyoD mediated by replication-independent histone deposition.

Authors:  Jae-Hyun Yang; Yunkyoung Song; Ja-Hwan Seol; Jin Young Park; Yong-Jin Yang; Jeung-Whan Han; Hong-Duk Youn; Eun-Jung Cho
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

5.  eRNAs promote transcription by establishing chromatin accessibility at defined genomic loci.

Authors:  Kambiz Mousavi; Hossein Zare; Stefania Dell'orso; Lars Grontved; Gustavo Gutierrez-Cruz; Assia Derfoul; Gordon L Hager; Vittorio Sartorelli
Journal:  Mol Cell       Date:  2013-08-29       Impact factor: 17.970

6.  Pitx2 is an upstream activator of extraocular myogenesis and survival.

Authors:  Amanda L Zacharias; Mark Lewandoski; Michael A Rudnicki; Philip J Gage
Journal:  Dev Biol       Date:  2010-10-28       Impact factor: 3.582

7.  Cranial muscle defects of Pitx2 mutants result from specification defects in the first branchial arch.

Authors:  Hung Ping Shih; Michael K Gross; Chrissa Kioussi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-23       Impact factor: 11.205

8.  Analysis of muscle creatine kinase gene regulatory elements in skeletal and cardiac muscles of transgenic mice.

Authors:  D B Donoviel; M A Shield; J N Buskin; H S Haugen; C H Clegg; S D Hauschka
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

9.  Musculin and TCF21 coordinate the maintenance of myogenic regulatory factor expression levels during mouse craniofacial development.

Authors:  Natalia Moncaut; Joe W Cross; Christine Siligan; Annette Keith; Kevin Taylor; Peter W J Rigby; Jaime J Carvajal
Journal:  Development       Date:  2012-03       Impact factor: 6.868

10.  Over-expression of the transcription factor, ZBP-89, leads to enhancement of the C2C12 myogenic program.

Authors:  Morgan Salmon; Gary K Owens; Zendra E Zehner
Journal:  Biochim Biophys Acta       Date:  2009-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.